PARP Inhibitors in Ovarian Cancer Treatment

N Engl J Med. 2016 Dec 1;375(22):2197-2198. doi: 10.1056/NEJMe1612843.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Poly(ADP-ribose) Polymerase Inhibitors*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Poly(ADP-ribose) Polymerase Inhibitors